Investigators compared early oncologic outcomes by staging modality among men diagnosed with very high-risk prostate cancer.

“Breast cancer survivors may have a slightly lower risk of AD compared with cancer-free individuals, potentially influenced by cancer treatments, underscoring the need for further research on ...

A higher NLR and rapid NLR shift between weeks 2 and 4 was strongly associated with RILD risk in patients with HCC.

Mild CMV reactivation was associated with beneficial effects, while severe cases required treatment, which increased the risk of toxicity and infections.

Cancer patients without health insurance have not derived the same benefits from the introduction of ICIs as patients with private insurance.

Lurbinectedin plus atezolizumab significantly reduced the risk of disease progression or death by 46% compared with atezolizumab alone.

Updated thresholds outperform those recommended by American Thyroid Association guidelines for patients with medullary thyroid cancer.

Omitting carboplatin could be an efficacious de-escalated neoadjuvant strategy in the presence of dual HER2 blockade for patients with HER2-positive early breast cancer,” said Kun Wang, MD, PhD.

Many young adult survivors of childhood hematologic cancer do not have comprehensive survivorship care summaries or believe they need one.

Despite the increasing numbers of men seeking careers in nursing, persistent stereotypes and other barriers continue to limit ...

Researchers reviewed cases in which patients experienced severe skin toxicities in response to immunotherapy, and sought to identify the distinct natures of these toxicities.

Using both liquid and tissue biopsies to guide targeted treatment may improve outcomes in patients with solid tumor malignancies.